HELP SCHEDULE 13G/A: SEC filing

OrbiMed Advisors LLC and OrbiMed Capital LLC

Filed with the SEC on · accession 0000947871-26-001034

HELP filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. OrbiMed Advisors LLC and OrbiMed Capital LLC filed an amended Schedule 13G disclosing passive beneficial ownership of approximately 1.9% of Helus Pharma Inc.'s common stock, including shares issuable upon exercise of warrants. The stock moved -13.5% by the first close after the filing.

Summary of the filing

OrbiMed Advisors LLC and OrbiMed Capital LLC filed an amended Schedule 13G disclosing passive beneficial ownership of approximately 1.9% of Helus Pharma Inc.'s common stock, including shares issuable upon exercise of warrants. The filing is a routine passive investment disclosure with no intent to influence control of the company.

Key details

Shares beneficially owned by OrbiMed Advisors LLC$496K
Shares beneficially owned by OrbiMed Capital LLC$848K
Aggregate shares beneficially owned by reporting persons$1.3M
Issuer of the securitiesHelus Pharma Inc.
Reporting person / beneficial ownerOrbiMed Advisors LLC
Reporting person / beneficial ownerOrbiMed Capital LLC
Member, orbimed advisors llc and orbimed capital llcCarl L. Gordon
Management committee member, orbimedW. Carter Neild
Management committee member, orbimedGeoffrey C. Hsu

How HELP stock reacted

Close before

$8.87

Nov 13, 2026

First close after

-13.53%

$7.67

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for HELP, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for HELP?

Click here

Frequently asked questions

What did HELP file with the SEC on Nov 16, 2026?

HELP filed a SCHEDULE 13G/A (SEC filing). OrbiMed Advisors LLC and OrbiMed Capital LLC filed an amended Schedule 13G disclosing passive beneficial ownership of approximately 1.9% of Helus Pharma Inc.'s common stock, including shares issuable upon exercise of warrants. The filing is a routine passive investment disclosure with no intent to influence control of the company.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did HELP stock react to this filing?

HELP closed at $8.87 before the filing and $7.67 on Nov 16, 2026 (-13.53%).

Other HELP SEC filings

Get alerts when HELP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days